CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Art Pappas to participate in panel discussion on "The Impact of Globalization in Healthcare" at the North Carolina Biotechnology Center.
News | 08. 15. 2006
